Dec

11

IOL Chemicals starts Iso Butyl Benzene production

Posted on: December 11, 2009 at 2:15 pm | 173 views




IOL Chemicals and Pharmaceuticals (IOLCP), one of the largest producers of APIs, Ibuprofen and specialty chemicals in India, has announced that keeping in line with its backward integration plans, the company has commenced the manufacturing operations at its new plant of Isobutyl Benzene (IBB) having annual capacity of 6600 MT to ensure ready availability of the basic raw material for its successful pharmaceutical product, the anti-inflammatory/analgesic drug, Ibuprofen.

The newly set up facilities for manufacturing of Iso Butyl Benezene are the second largest in India in terms of manufacturing capacity.

R K Thukral, executive director, IOL Chemicals and Pharmaceuticals, said, “The latest development makes IOLCP more self reliant in terms of procurement of raw materials for Ibuprofen and therefore will enable us to cater to the burgeoning demand for the same from several new markets worldwide. We expect the next fiscal to be extremely exciting for us as we start exporting to newer markets with ready demand and ample of opportunities.“

The production capacity of Ibuprofen has been the stronghold of IOLCP`s pharmaceutical operations and the company has recently increased its Ibuprofen plant capacity to 3600 TPA. Ibuprofen is used to reduce fever and treat pain or inflammation caused by many ailments such as headache, toothache, back pain, arthritis, menstrual cramps, or minor injuries.

IOLCP has also recently commenced operations of Mono Chloro Acetic Acid(MCA) with a capacity of 7200 TPA and Acetyl Chloride with a capacity of 5200 TPA, other major raw materials for the manufacture of Ibuprofen using Acetic Acid and Acetic Anhydride as a raw material.

IOLCP has also received DMF registration numbers from United States Food & Drug Administration (USFDA) and also from Health Canada, the drug regulatory body of Canada for exporting Ibuprofen to these countries. IOLCP has also secured acknowledgment of Certificate of Suitability from EDQM (European Directorate for the Quality of Medicines & HealthCare) to export Ibuprofen into the European countries. IOLCP aims to tap new export markets such as France, Russia, Korea and Taiwan for Ibuprofen and is already exporting its various products to over 52 countries across the world including Argentina, Brazil, China, Denmark, Germany, Singapore, Hong Kong, Kenya, Malaysia, Peru, Egypt, Nigeria , Ghana , Philippines etc.

“The lucrative markets of Canada, US and Europe offer immense potential for the export of Ibuprofen as active pharmaceuticals ingredient (API). We foresee export potential of about 2,000 TPA and 300 TPA in Canada and Australia respectively. We are confident our commitment to the quality of our products will enable us to achieve our targeted growth,“ added RK Thukral.

  • Share/Save/Bookmark




Tags:, , , , , , , , , , , , , , ,

Related Post :


  • Search

  • Investment Books

  • Smart Investment